Skip to main content

ROSEVILLE, Minn., March 14, 2022 — VitalPath, a manufacturer of custom, highly complex catheter solutions, recently announced three key management positions to support business growth and position the company to meet current and future customer needs. The move follows the company’s acquisition of a third Minneapolis-area facility in January 2022, bringing its total employees to more than 350.

Shawn Cheesman is the new Site Manager at VitalPath’s Cokato, MN facility. He brings a wealth of general management experience including overseeing manufacturing, operations, quality, and product development organizations. Previously, he served as General Manager at Lou-Rich, a contract manufacturer for a variety of industries, including medical equipment. He has a bachelor’s degree in engineering from Purdue University and an MBA from the University of Minnesota.

Gary LaTraille is VitalPath’s new Director of Quality Assurance. Gary brings more than 25 years of broad experience in medical device QA /QC /Regulatory. Previously, he served as Director of Quality Assurance at Diversified Plastics. A familiar face, Gary has also conducted internal audits for us as an industry consultant. He has a bachelor’s degree from Metropolitan State University.

Tee Yang has accepted the newly created position of Director of Continuous Improvement (CI). A VitalPath team member for more than 10 years, he previously served as Director of Operations. Tee will oversee CI efforts at all 3 facilities, implementing a robust CI program to improve efficiencies and productivity, reduce cost, and implement Lean manufacturing.

About VitalPath

VitalPath manufactures custom, highly complex catheter solutions for medical device OEMs. The company specializes in meeting customers’ most challenging requirements, like single or multidirectional deflection, pushability, kink resistance and torque response. With more than 20 years of experience, VitalPath serves customers in the cardiovascular, electrophysiology, neurovascular, peripheral vascular and structural heart markets.

VitalPath comprises the companies formerly known as Catheter & Medical Design LLC (CMD); VitalDyne Medical Inc., which CMD acquired in March 2021; and Modern Catheter Technologies, acquired in January 2022. Headquartered in the Minneapolis area, VitalPath is ISO 13485:2016 certified and has an FDA-registered facility.

Close Menu

About VitalPath

VitalPath is the new name for the merging of VitalDyne Medical & Catheter and Medical Design. We’re ISO 13485:2016 certified and FDA registered.